EUCR
Eucrates Biomedical Acquisition Corp. Ordinary Shares
EUCR
EUCR
Delisted
EUCR was delisted on the 26th of April, 2023.
5 hedge funds and large institutions have $2.98M invested in Eucrates Biomedical Acquisition Corp. Ordinary Shares in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
5
Holding in Top 10
–
Calls
–
Puts
–
Top Sellers
| 1 | -$10.2M | |
| 2 | -$10M | |
| 3 | -$9.02M | |
| 4 |
D.E. Shaw & Co
New York
|
-$6.68M |
| 5 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$6.53M |